Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Active, not recruiting	Phase 2	2026-01-23		NCT05807880

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	88
Sun Yat-sen University	606

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sun Yat-Sen University Cancer Center	Guangzhou	China	113

Clinical trials